Jun 21, “There are women who, for no known reason, have reduced sexual desire In , the FDA identified female sexual dysfunction as one of
On October 27, , FDA held a public meeting to hear perspectives from women with female sexual dysfunction (FSD) on their condition and on currently .
44 substance/medication-induced sexual dysfunction in women. 67 The term female sexual dysfunction encompasses a heterogeneous group of sexual.
The purpose of this guidance is to assist sponsors in developing drugs for the treatment of low sexual interest, desire, and/or arousal in women. Specifically, this.
Jun 21, Instead, women with HSDD have "previously experienced no problems with sexual desire," the FDA said. "Generalized HSDD refers to HSDD.